On the topic of patient number growth, Evert month, there are children turning 2 years old whose parents have been eagerly waiting for this milestone to start treatment for Rett syndrome. Probably a moment filled with hope and anticipation for the potential benefits of early intervention.
As we've seen remarkable outcomes in older children and adults who have lived with Rett syndrome for years, the question arises.... what does the future hold for a 2-year-old starting treatment with Daybue? Could early treatment potentially slow or even halt the progression of the disorder?
Given the incredible progress reported in individuals who have started treatment, I think it's exciting to consider the possibilities for young children who are just beginning their treatment journey. The potential for improved outcomes and a better quality of life is a promising prospect for families affected by Rett syndrome.
NEU Price at posting:
$12.77 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)